CoChat

Economic and cost-effectiveness analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials in India, Pakistan and Mozambique

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: The Community-Level Interventions for Pre-eclampsia (CLIP) trials (NCT01911494) in India, Pakistan and Mozambique (February 2014–2017) involved community engagement and task sharing with community health workers for triage and initial treatment of pregnancy hypertension. Maternal and perinatal mortality was less frequent among women who received ≥8 CLIP contacts. The aim of this analysis was to assess the incremental costs and cost-effectiveness of the CLIP intervention overall in comparison to standard of care, and by PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move (POM) mobile health application visit frequency. Methods: Included were all women enrolled in the three CLIP trials who had delivered with known outcomes by trial end. According to the number of POM-guided home contacts received (0, 1–3, 4–7, ≥8), costs were collected from annual budgets and spending receipts, with inclusion of family opportunity costs in Pakistan. A decision tree model was built to determine the cost-effectiveness of the intervention (vs usual care), based on the primary clinical endpoint of years of life lost (YLL) for mothers and infants. A probabilistic sensitivity analysis was used to assess uncertainty in the cost and clinical outcomes. Results: The incremental per pregnancy cost of the intervention was US$12.66 (India), US$11.51 (Pakistan) and US$13.26 (Mozambique). As implemented, the intervention was not cost-effective due largely to minimal differences in YLL between arms. However, among women who received ≥8 CLIP contacts (four in Pakistan), the probability of health system and family (Pakistan) cost-effectiveness was ≥80% (all countries). Conclusion: The intervention was likely to be cost-effective for women receiving ≥8 contacts in Mozambique and India, and ≥4 in Pakistan, supporting WHO guidance on antenatal contact frequency. Trial registration number: NCT01911494.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjgh-2020-004123

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Probabilistic sensitivity analyses of cost-effectiveness by number of POM-guided contacts received. Points in the north-east quadrant are classified as cost-effective. All data are per 1000 pregnancies. ctrl, control; int, intervention; POM, PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move.
Figure 1 Probabilistic sensitivity analyses of cost-effectiveness by number of POM-guided contacts received. Points in the north-east quadrant are classified as cost-effective. All data are per 1000 pregnancies. ctrl, control; int, intervention; POM, PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move.CC BY · PubMed Central
Figure 2 Cost-effectiveness acceptability curves by number of POM-guided contacts received: probability that the intervention is cost-effective as a function of a decision-maker’s willingness to pay to save 1 year of life lost. The vertical red line represents country-specific willingness-to-pay thresholds based on 1× and 3× the gross domestic product (GDP) per capita. The vertical blue lines represent the low and high points of country-specific willingness-to-pay ranges from Woods et al 23 POM, PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move; YLL, years of life lost.
Figure 2 Cost-effectiveness acceptability curves by number of POM-guided contacts received: probability that the intervention is cost-effective as a function of a decision-maker’s willingness to pay to save 1 year of life lost. The vertical red line represents country-specific willingness-to-pay thresholds based on 1× and 3× the gross domestic product (GDP) per capita. The vertical blue lines represent the low and high points of country-specific willingness-to-pay ranges from Woods et al 23 POM, PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move; YLL, years of life lost.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 17

Metadata

Authors
Bone, J. N., Khowaja, A. R., Vidler, M., Payne, B. A., Bellad, M. B., Goudar, S. S., Mallapur, A. A., Munguambe, K., Qureshi, R. N., Sacoor, C., Sevene, E., Frederix, G. W. J., Bhutta, Z. A., Mitton, C., Magee, L. A., & von Dadelszen, P.
Affiliations
  • University of British Columbia (CA)
  • KLE Academy of Higher Education and Research (IN)
  • S Nijalingappa Medical College and HSK Hospital & Research Centre (IN)
  • Centro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique
  • Aga Khan University (PK)
  • Manhiça Health Research Centre (MZ)
  • Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands
  • Department of Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada
Venue
BMJ Global Health
Publisher
BMJ
Published
2021-05
Volume
6
Issue
5
Pages
e004123
ISSN
2059-7908 (ISSN-L)
OpenAlex
W3165354911
Cited by
14
References
38
Citations by year
2026: 5 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1
FWCI
1.48
Type
journal article
Language
en
Open access
Locations
  • BMJ Global Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eCommons - AKU (Aga Khan University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Greater South Information System
Funders
Bill and Melinda Gates Foundation (OPP1017337)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
preeclampsia, cost-effectiveness, community health workers, task sharing, hypertensive disorders of pregnancy, prenatal care, mobile health, years of life lost, maternal mortality, perinatal mortality, India, Pakistan, Mozambique
MeSH terms
Cost-Benefit Analysis, Female, Humans, India, Infant, Mozambique, Pakistan, Pre-Eclampsia, Pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Economic and cost-effectiveness analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials in India, Pakistan and Mozambique. https://app.cochat.ai/papers/10.1136/bmjgh-2020-004123
The paper
Bone, J. N., Khowaja, A. R., Vidler, M., Payne, B. A., Bellad, M. B., Goudar, S. S., Mallapur, A. A., Munguambe, K., Qureshi, R. N., Sacoor, C., Sevene, E., Frederix, G. W. J., Bhutta, Z. A., Mitton, C., Magee, L. A., & von Dadelszen, P. (2021). Economic and cost-effectiveness analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials in India, Pakistan and Mozambique. BMJ Global Health. https://doi.org/10.1136/bmjgh-2020-004123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.